Thanks to a $500,000 investment from Ontario’s Investor Accelerator Fund, Kanata-based eSight will be able to bring their “evSpex” to the global market.  For people with inoperable low vision, this new technology means improved sight.  The evSpex consists of a wearable headset and a touch screen unit where users input their settings.  With this investment, eSight expects to grow by 25 people in the next two years. (eSight President, Rob Hilkes)

Download
(2,190, x 2,856 pixels, 72 DPI, 2.6MB)

Thanks to a $500,000 investment from Ontario’s Investor Accelerator Fund, Kanata-based eSight will be able to bring their “evSpex” to the global market.  For people with inoperable low vision, this new technology means improved sight.  The evSpex consists of a wearable headset and a touch screen unit where users input their settings.  With this investment, eSight expects to grow by 25 people in the next two years.

Download
(3,707 x 2,112 pixels, 72 DPI, 3.4MB)

Thanks to a $500,000 investment from Ontario’s Investor Accelerator Fund, Kanata-based eSight will be able to bring their “evSpex” to the global market.  For people with inoperable low vision, this new technology means improved sight.  The evSpex consists of a wearable headset and a touch screen unit where users input their settings.  With this investment, eSight expects to grow by 25 people in the next two years.

Download
(3,888 x 2,592 pixels, 72 DPI, 4.3MB)

Thanks to a $500,000 investment from Ontario’s Investor Accelerator Fund, Kanata-based eSight will be able to bring their “evSpex” to the global market.  For people with inoperable low vision, this new technology means improved sight.  The evSpex consists of a wearable headset and a touch screen unit where users input their settings.  With this investment, eSight expects to grow by 25 people in the next two years.

Download
(2,728 x 1,535 pixels, 72 DPI, 0.3MB)

Minister of Research and Innovation John Milloy at the Ontario Institute for Cancer Research (OICR).


Pfizer Global Research and Development is joining forces with the McGuinty government and Ontario researchers to develop a new generation of drugs to fight colorectal cancer.

Download
(3,504 x 2,336 pixels, 300 DPI, 3.4MB)

Photo (left to right): Minister of Health and Long-Term Care, David Caplan; Minister of Research and Innovation, John Milloy; President and Scientific Director of the Ontario Institute for Cancer Research, Dr. Tom Hudson; President of Pfizer Canada, Paul Lévesque; and lead researcher on the collaboration from the Ontario Cancer Institute at Princess Margaret Hospital, Dr. Bradly Wouters.

Pfizer Global Research and Development is joining forces with the McGuinty government and Ontario researchers to develop a new generation of drugs to fight colorectal cancer.

Download
(3,504 x 2,336 pixels, 300 DPI, 2.8MB)

Minister of Health and Long-Term Care David Caplan and Minister of Research and Innovation John Milloy tour the Ontario Institute for Cancer Research’s cutting-edge research laboratories.

Pfizer Global Research and Development is joining forces with the McGuinty government and Ontario researchers to develop a new generation of drugs to fight colorectal cancer.

Download
(3,504 x 2,336 pixels, 300 DPI, 3.3MB)

Sentinelle Medical Inc. — Sentinelle’s technology improves the performance of MRI (Magnetic Resonance Imaging) breast cancer detection. Sentinelle has developed a technique to improve MRI detection of breast cancer, resulting in shorter testing time, reduced costs, better images and 3-D visualization software for reading MR images.

Download
(3,504 x 2,336 pixels, 300 DPI, 5.4MB)

Sentinelle Medical Inc. — Sentinelle’s technology improves the performance of MRI (Magnetic Resonance Imaging) breast cancer detection. Sentinelle has developed a technique to improve MRI detection of breast cancer, resulting in shorter testing time, reduced costs, better images and 3-D visualization software for reading MR images.

Download
(3,504 x 2,336 pixels, 300 DPI, 4MB)

Sentinelle Medical Inc. — Sentinelle’s technology improves the performance of MRI (Magnetic Resonance Imaging) breast cancer detection. Sentinelle has developed a technique to improve MRI detection of breast cancer, resulting in shorter testing time, reduced costs, better images and 3-D visualization software for reading MR images.

Download
(3,504 x 2,336 pixels, 300 DPI, 3.6MB)

Sentinelle Medical Inc. — Sentinelle’s technology improves the performance of MRI (Magnetic Resonance Imaging) breast cancer detection. Sentinelle has developed a technique to improve MRI detection of breast cancer, resulting in shorter testing time, reduced costs, better images and 3-D visualization software for reading MR images.

Download
(2,388 x 2,336 pixels, 300 DPI, 2.4MB)

Microscope

Download
(2,254 x 1,500 pixels, 300 DPI, 1.3MB)

Beaker

Download
(4,088 x 6,144 pixels, 240 DPI, 11.2MB)

Woman and microscope

Download
(6,144 x 4,088 pixels, 240 DPI, 10MB)

Vial

Download
(4,088 x 6,144 pixels, 240 DPI, 9.3MB)

Woman and Vials

Download
(4,088 x 6,144 pixels, 240 DPI, 8MB)

Thanks to a $500,000 investment from Ontario’s Investor Accelerator Fund, Kanata-based eSight will be able to bring their “evSpex” to the global market.  For people with inoperable low vision, this new technology means improved sight.  The evSpex consists of a wearable headset and a touch screen unit where users input their settings.  With this investment, eSight expects to grow by 25 people in the next two years. (eSight President, Rob Hilkes)

Download
(Quicktime H.264, 1280x720, 152MB)

STTARR Laboratory – Spatio-Temporal Targeting and Amplification of Radiation Response

The STTARR program maximizes the development of effective cancer treatment strategies including radiation therapy, by integrating cellular, pre-clinical and human research. Program research aims to understand the dynamics of tumour and normal tissue as it responds to radiation.

Download
(Quicktime H.264, 1280x720, 54MB)

The Ontario Institute for Cancer Research (OICR) is dedicated to research in prevention, early detection, diagnosis and treatment of cancer.

Download
(Quicktime H.264, 1280x720, 428MB)

The Ontario Institute for Cancer Research (OICR) is dedicated to research in prevention, early detection, diagnosis and treatment of cancer.

Download
(Quicktime H.264, 1280x720, 418MB)

The Ontario Institute for Cancer Research (OICR) is dedicated to research in prevention, early detection, diagnosis and treatment of cancer.

Download
(Quicktime H.264, 1280x720, 600MB)

The Ontario Institute for Cancer Research (OICR) is dedicated to research in prevention, early detection, diagnosis and treatment of cancer.

Download
(Quicktime H.264, 1280x720, 682MB)